SARS-CoV

CAS No.	Product Name	Inquiry
2722635-28-9	SARS-CoV-2-IN-11 SARS-CoV-2 3C-like protease (3CLpro), an enzyme essential for viral replication. SARS-CoV-2-IN-11 may be a potent and nontoxic inhibitor of SARS-CoV-2 3CL protease.
2725749-22-2	SARS-CoV-2-IN-6
2735704-15-9	INSCoV-600K-1 INSCoV-600K(1) is a potent inhibitor of Mpro (3CLpro). Proteases (PL pro and 3CL pro) are involved with transcription and replication of the virus. INSCoV-600K(1) has the potential for the research of SARS-CoV-2 infection.
2735704-19-3	INSCoV-601I-1 INSCoV-601I(1) is a potent inhibitor of Mpro (3CLpro). Proteases (PL pro and 3CL pro) are involved with transcription and replication of the virus. INSCoV-601I(1) has the potential for the research of SARS-CoV-2 infection.
2735704-33-1	INSCoV-614-1B INSCoV-614(1B) is a potent inhibitor of Mpro (3CLpro). Proteases (PL pro and 3CL pro) are involved with transcription and replication of the virus. INSCoV-614(1B) has the potential for the research of SARS-CoV-2 infection.
2738323-08-3	SARS-CoV-2-IN-75
2738376-78-6	Amprenavir-d4-1 Amprenavir-d4-1 is deuterium labeled Amprenavir. Amprenavir (VX-478) is a HIV protease inhibitor (Ki=0.6 nM) used to treat HIV infection. Amprenavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.09 μM.
2747915-85-9	Azelastine-d4 hydrochloride
2748522-40-7	Ketotifen-13C,d3
2754370-99-3	SARS-CoV-2 Mpro-IN-9
2755812-39-4	Ibuzatrelvir
2755957-14-1	GRL-190-21
2757194-03-7	FWM-4 FWM-4 is a potent SARS-COV-2 NSP13 helicase enzyme inhibitor.
2757194-04-8	FWM-5 FWM-5 is a potent NSP13 helicase inhibitor. SARS-COV-2 NSP13 helicase enzyme plays crucial role in the virus life cycle.
2757470-18-9	Ensitrelvir fumarate Ensitrelvir fumarate is the first orally active, non-covalent and non-peptidic inhibitor of SARS-CoV-2 3CL protease with an IC50 of 13 nM.
2757763-47-4	SARS-CoV-2-IN-35
2757970-20-8	SARS-CoV-2-3CLpro-IN-1 SARS-CoV-2 3CLpro-IN-1 (Compound 14c) is a potent inhibitor of SARS-CoV-2 3CLpro. 3CLpro (main coronaviruses cysteine-protease) has been identified as a promising target for the development of antiviral drugs. SARS-CoV-2 3CLpro-IN-1 has the potential for the research of infection diseases.
2758278-51-0	3CPLro-IN-2 3CPLro-IN-2 is a potent and orally active inhibitor of SARS-CoV-2 3CLpro with an IC50 and Ki of 1.55 and 6.09 μM, respectively. 3-Chymotrypsin-like cysteine protease (3CLpro) is an indispensable protein in viral replication and represents an attractive drug target for fighting COVID-19.
2758359-91-8	SARS-CoV-2-Mpro-IN-1 SARS-CoV-2 Mpro-IN-1 (compound 16b-3) is a potent, selective and irreversible inhibitor of SARS-CoV-2 main protease(Mpro), with an IC50 of 116 nM.
2759996-93-3	Tirfipiravir

※ Please kindly note that our services are for research use only.